Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | March 2022
The Regulator has confirmed that it will take a flexible approach when it comes to review the first wave of mandatory reports on climate change risks.
A Regulator spokesman gave this reassurance in a speech at a recent conference of the Pensions and Lifetime Savings Association (PLSA).
This is consistent with previous messaging from the Regulator, recognising that undertaking governance and reporting in line with the Taskforce for Climate-related Financial Disclosures (TCFD) is a new area for pension schemes and their advisers. There may also be an issue, at least initially, with the availability and quality of data.
Trustees that fail to produce a report will receive a mandatory fine but the Regulator spokesman highlighted that penalties for reports which fell short of the full requirements were discretionary. The Regulator plans to look at “the bigger picture” rather than focussing on technicalities.
This will no doubt be welcomed by the largest occupational pension schemes and master trusts which are having to grapple with the new requirements first. However, the Regulator has also put down a marker that it will expect standards to improve over time.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025